Chemed Corporation $CHE Shares Sold by Fort Washington Investment Advisors Inc. OH

Fort Washington Investment Advisors Inc. OH cut its stake in Chemed Corporation (NYSE:CHE) by 3.4% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 38,392 shares of the company’s stock after selling 1,363 shares during the quarter. Fort Washington Investment Advisors Inc. OH’s holdings in Chemed were worth $18,694,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of CHE. Alpine Bank Wealth Management purchased a new stake in shares of Chemed in the first quarter valued at about $29,000. HM Payson & Co. acquired a new position in Chemed in the 1st quarter valued at about $30,000. SVB Wealth LLC purchased a new stake in shares of Chemed in the 1st quarter valued at approximately $30,000. Whipplewood Advisors LLC increased its holdings in shares of Chemed by 54.5% during the 1st quarter. Whipplewood Advisors LLC now owns 51 shares of the company’s stock worth $31,000 after buying an additional 18 shares during the last quarter. Finally, WPG Advisers LLC purchased a new stake in shares of Chemed during the 1st quarter valued at approximately $32,000. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Trading Up 2.6%

CHE stock opened at $462.30 on Monday. The business’s fifty day moving average price is $450.29 and its 200 day moving average price is $520.75. Chemed Corporation has a 12-month low of $408.42 and a 12-month high of $623.60. The company has a market capitalization of $6.74 billion, a PE ratio of 23.77, a P/E/G ratio of 2.69 and a beta of 0.46.

Chemed (NYSE:CHE) last released its earnings results on Tuesday, July 29th. The company reported $4.27 earnings per share for the quarter, missing the consensus estimate of $6.02 by ($1.75). The firm had revenue of $618.80 million during the quarter, compared to analyst estimates of $650.60 million. Chemed had a net margin of 11.56% and a return on equity of 25.83%. The business’s revenue was up 3.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $5.47 earnings per share. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Research analysts predict that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Monday, August 11th were paid a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend was Monday, August 11th. This is an increase from Chemed’s previous quarterly dividend of $0.50. Chemed’s payout ratio is currently 12.34%.

Analyst Ratings Changes

Several brokerages recently weighed in on CHE. Royal Bank Of Canada lowered their price objective on Chemed from $640.00 to $589.00 and set an “outperform” rating for the company in a research report on Thursday, July 31st. Bank of America lowered their price target on Chemed from $610.00 to $595.00 and set a “buy” rating for the company in a report on Wednesday, September 10th. Jefferies Financial Group upgraded shares of Chemed from a “hold” rating to a “buy” rating and boosted their price objective for the company from $490.00 to $550.00 in a report on Tuesday, September 2nd. Wall Street Zen cut shares of Chemed from a “buy” rating to a “hold” rating in a research report on Saturday, July 5th. Finally, Oppenheimer dropped their price target on shares of Chemed from $650.00 to $580.00 and set an “outperform” rating for the company in a research report on Thursday, July 31st. Four equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company has an average rating of “Buy” and an average target price of $578.50.

Insiders Place Their Bets

In other Chemed news, Director Patrick P. Grace sold 150 shares of the firm’s stock in a transaction that occurred on Tuesday, September 9th. The shares were sold at an average price of $463.39, for a total value of $69,508.50. Following the completion of the transaction, the director owned 3,397 shares of the company’s stock, valued at $1,574,135.83. This trade represents a 4.23% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, EVP Nicholas Michael Westfall sold 10,012 shares of the business’s stock in a transaction on Monday, August 4th. The stock was sold at an average price of $421.91, for a total transaction of $4,224,162.92. The disclosure for this sale can be found here. 3.29% of the stock is owned by company insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.